We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
28 August 2014
Covagen AG is acquired by an affiliate of Janssen Pharmaceutical which belongs to Johnson & Johnson. Covagen AG, located in Schlieren near Zurich, is a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through FynomAb® by fusing fully human Fynomer binding proteins to antibodies. Covagen was co-founded in 2007 by Julian Bertschinger and Dragan Grabulovski as a spin-off company of ETH Zurich, Switzerland. VISCHER has been assisting Covagen in its inception, has been advising Covagen in all its financing rounds as well as major collaborations and has now acted for Covagen for Swiss law matters in its sale. The team is lead by Matthias Staehelin with Ruben Masar (Corporate), Nadia Tarolli (Tax) and Melanie Knüsel (Tax).
Categories: Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Startup Desk, Deals & Cases
Attorney at Law / Honorary Consul of the Slovak Republic
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law, Swiss Certified Tax Expert (2008)
Datum: 8. November 2022 (Zürich) & 10. November 2022 (Basel) Veranstalter: VISCHER AG...
Frankfurt-based Mainova AG has acquired a majority stake in Bavarian energy service provider...
Am 29. Oktober findet die "Nacht der jungen Leaders" zum zweiten Mal im Rhypark statt.